News

/News

CURE welcomes new member AlloThera

AlloThera is a seed stage company launched in 2016 with laboratories located at 5 Science Park in New Haven. Founded by Craig Crews and backed by Canaan Partners, AlloThera is working to identify novel inhibitors of enzymes that historically have been difficult to drug.​ more

By |October 26th, 2017|News|0 Comments

CURE welcomes Dawn Hocevar as new CEO

CURE is pleased to welcome Dawn Hocevar as CURE's new president and CEO, effective October 16. Most recently she has been Vice President, Business Development at BioSurplus Inc., as well as President and Board Chair of Women in Bio, a leading non-profit with 13 chapters and 2000 members. She is a resident of Branford, CT. As previously announced, Dr. Susan Froshauer is stepping down as head of CURE after four years in office. "We want to thank Susan for all she has accomplished and we look forward to working with Dawn," said Peter Farina, Co-Chair of CURE and Stanley Choy, Co-Chair [...]

By |October 16th, 2017|News|0 Comments

Meet 30 biotech leaders under 40

Because many of those in the biotechnology and pharmaceutical industries attend graduate school for years before joining a company, leaders under the age of 40 and especially 30 tend to be less common than in other industries. Business Insider came up with a list of 30 leaders who are shaping the future of medicine. Colleen Coffura of Canaan Partners and Julia Oh of the Jackson Laboratory were among those cited. more

By |October 16th, 2017|News|0 Comments

CI seeks bioscience venture capital manager

Connecticut Innovations is seeking a high-caliber professional to assist with the investment of bioscience venture capital from the $200 million Connecticut Bioscience Innovation Fund. Qualified candidates must have, at minimum, a master's degree in science and seven (7) years of experience in life science venture capital, or business development/commercialization experience in a high-growth, entrepreneurial biotechnology or pharmaceutical company, preferably venture-backed. more

By |October 16th, 2017|News|0 Comments

FDA finalizes product classification guidance

The FDA has combined and finalized two Draft Guidance documents first issued in 2011 that set forth the Agency’s approach to classifying products as “drugs” or “devices” under the FDC Act § 201. In doing so, FDA trimmed significant portions of both Draft Guidance documents ostensibly “for clarity and ease of reference.​” more

By |October 16th, 2017|News|0 Comments

Mobile Sense lands $225k for clinical trial

Farmington's Mobile Sense Technologies has been awarded a $225,000 federal grant to support a clinical trial of its wearable technology meant to detect abnormal heart rhythms called arrhythmias. more

By |October 16th, 2017|News|0 Comments

Sema4 partners with PWNHealth re genetic testing

Sema4, a sequencing and informatics startup spun out of New York's Mount Sinai Health System, is partnering with telehealth company PWNHealth to offer physician-backed genetic testing to consumers nationwide ​... more Separately, Sema4,  has named Jamie Coffin as its new president and COO. Coffin, who has a Ph.D. in computational chemistry, was previously CEO of Source Medical Solutions Inc., a provider of practice management and electronic medical record solutions for the ambulatory surgical space ... more

By |October 16th, 2017|News|0 Comments

IsoPlexis raises $13.5 million in Series B financing

IsoPlexis Corporation has raised $13.5 million in a Series B financing round. The round was led by Spring Mountain Capital, with participation by Connecticut Innovations, North Sound Ventures, and Ironwood Capital. IsoPlexis, a privately held life sciences company, is developing novel technologies at the forefront of the revolution in immunity-based treatments of cancer. more

By |October 16th, 2017|News|0 Comments

3 Americans win 2017 Nobel Prize in Medicine

The 2017 Nobel Prize in physiology or medicine was awarded on Monday morning to Jeffrey Hall, Michael Rosbash, and Michael Young for their discoveries of the molecular underpinnings of the circadian rhythms that help organisms adapt to our 24-hour days. The scientists “were able to peek inside our biological clock and elucidate its inner workings,” said Thomas Perlmann, secretary of the Nobel Committee for Physiology or Medicine, who announced the prize in Stockholm. “Their discoveries explain how plants, animals, and humans adapt their biological rhythm so that it is synchronized with the Earth’s revolutions.” Hall, of Brandeis University; Rosbash, also [...]

By |October 16th, 2017|News|0 Comments

Two new members join The Commons Advisory Committee

The Commons is pleased to welcome Jayson Bernstein, President of American Laboratory Trading (ALT) and J. Richard Lee, Managing Director of O,R&L Commercial to The Commons Advisory Committee. Mr. Bernstein joined American Laboratory Trading, Inc. (ALT) in 2009 and has served as its president since 2015. Headquartered in East Lyme, CT, ALT provides two key services – as a leading supplier of premium refurbished lab equipment and as a prominent provider of surplus lab asset management solutions for labs around the world. Under his direction, ALT has sustained continuous growth highlighted by the grand opening of their west coast facility [...]

By |October 16th, 2017|News|0 Comments